Lubor Gaal
Director of Finance/CFO presso CIRCIO HOLDING ASA
Patrimonio netto: 1 $ in data 31/03/2024
Profilo
Lubor Gaal is currently an Independent Director at Trex Wind-down, Inc. and the Chief Financial Officer at Circio Holding ASA. Previously, he worked at Bristol Myers Squibb Co. as the Head of Neuroscience, Immunoscience & Fibrosis from 2006 to 2015.
He also held positions at Bayer AG as the Head of CNS & CV Licensing, Almirall SA as the Head of External Innovation & Licensing, Neuro3D SA as the Head of Sales & Marketing, and Locust Walk Partners LLC as the Senior Vice President & Head of Europe.
Dr. Gaal obtained his undergraduate degree from the University of Sussex and his doctorate degree from the University of California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TREX WIND DOWN INC
0.10% | 07/09/2023 | 3 366 ( 0.10% ) | 1 $ | 31/03/2024 |
Posizioni attive di Lubor Gaal
| Società | Posizione | Inizio |
|---|---|---|
| TREX WIND-DOWN, INC. | Director/Board Member | 19/08/2020 |
| CIRCIO HOLDING ASA | Director of Finance/CFO | 07/03/2022 |
Precedenti posizioni note di Lubor Gaal
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2015 |
| BAYER AG | Corporate Officer/Principal | - |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - |
Neuro3D SA
 Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Sales & Marketing | - |
Formazione di Lubor Gaal
| University of Sussex | Undergraduate Degree |
| University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BAYER AG | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| CIRCIO HOLDING ASA | Health Technology |
| Aziende private | 3 |
|---|---|
Neuro3D SA
Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Commercial Services |
| Timber Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Lubor Gaal
